1. Home
  2. WST vs SUI Comparison

WST vs SUI Comparison

Compare WST & SUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • SUI
  • Stock Information
  • Founded
  • WST 1923
  • SUI 1975
  • Country
  • WST United States
  • SUI United States
  • Employees
  • WST N/A
  • SUI N/A
  • Industry
  • WST Medical/Dental Instruments
  • SUI Real Estate Investment Trusts
  • Sector
  • WST Health Care
  • SUI Real Estate
  • Exchange
  • WST Nasdaq
  • SUI Nasdaq
  • Market Cap
  • WST 18.9B
  • SUI 15.9B
  • IPO Year
  • WST N/A
  • SUI 1993
  • Fundamental
  • Price
  • WST $250.86
  • SUI $129.82
  • Analyst Decision
  • WST Buy
  • SUI Buy
  • Analyst Count
  • WST 7
  • SUI 14
  • Target Price
  • WST $332.50
  • SUI $138.21
  • AVG Volume (30 Days)
  • WST 501.4K
  • SUI 859.4K
  • Earning Date
  • WST 10-23-2025
  • SUI 11-05-2025
  • Dividend Yield
  • WST 0.35%
  • SUI 3.20%
  • EPS Growth
  • WST N/A
  • SUI 1883.93
  • EPS
  • WST 6.68
  • SUI 10.23
  • Revenue
  • WST $2,960,200,000.00
  • SUI $3,217,100,000.00
  • Revenue This Year
  • WST $6.28
  • SUI N/A
  • Revenue Next Year
  • WST $6.02
  • SUI $4.21
  • P/E Ratio
  • WST $37.51
  • SUI $12.90
  • Revenue Growth
  • WST 2.90
  • SUI 17.94
  • 52 Week Low
  • WST $187.43
  • SUI $109.22
  • 52 Week High
  • WST $352.33
  • SUI $147.83
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.03
  • SUI 60.66
  • Support Level
  • WST $241.64
  • SUI $124.47
  • Resistance Level
  • WST $248.66
  • SUI $126.99
  • Average True Range (ATR)
  • WST 4.85
  • SUI 1.98
  • MACD
  • WST -0.17
  • SUI 0.23
  • Stochastic Oscillator
  • WST 92.22
  • SUI 82.31

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About SUI Sun Communities Inc.

Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 502 properties, which includes 337 manufactured housing communities and 165 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.

Share on Social Networks: